Form 4: Edwards Lifesciences Executive Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Catherine M. Szyman, CVP at Edwards Lifesciences, disposed of 827 shares of common stock on May 11, 2024, to cover tax obligations.
Summary
- On May 11, 2024, Catherine M. Szyman, a CVP at Edwards Lifesciences, disposed of 827 shares of common stock.
- The transaction was executed to cover tax obligations related to equity compensation.
- The shares were disposed of at a price of $86.72 per share.
- Following the transaction, Szyman directly owns 76,165.4373 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to a routine stock disposal for tax purposes and doesn't indicate any significant positive or negative implications for the company.
Industry Context
Executive stock transactions are a routine part of corporate governance and are closely watched by investors for insights into management's perspective on the company's value and future prospects. This transaction appears to be related to tax obligations, which is a common reason for such disposals.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine disposal of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/11/2024 | Date of stock disposal transaction. |
| 05/13/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.